Pfizer CFO Dave Denton to Depart; Cecile Guegan Appointed Interim CFO

Pfizer announced that Chief Financial Officer Dave Denton will step down from his role, effective August 15, 2026, to pursue an opportunity outside the pharmaceutical industry. The company has appointed Cecile Guegan, a long-tenured finance executive at Pfizer, as Interim CFO, effective August 16, 2026. Pfizer has initiated a comprehensive search for a permanent successor.

Key Details

• Departing Executive: Dave Denton, Chief Financial Officer.
• Effective Departure Date: August 15, 2026.
• Reason for Departure: The filing states the departure is for a new role in the consumer goods industry and is not related to Pfizer's financial performance, operations, or any disagreements.
• Interim Appointment: Cecile Guegan, currently SVP, Finance, Global Biopharmaceutical Business, will serve as Interim CFO, effective August 16, 2026.